SUBSCRIBE
SUBSCRIBE
News   Business

Teva Pharmaceutical Industries Limited Q3 Profit Higher as Copaxone Sales Jump

November 3, 2009 | 
1 min read

Bookmark and Share

Reuters -- Teva Pharmaceutical Industries, the world’s largest generic drugmaker, reported higher quarterly net profit on Tuesday, boosted by sales of its multiple sclerosis drug Copaxone and respiratory business.

Earnings
MORE ON THIS TOPIC
Art collage, hands and scales of justice. The concept of the law of the judge.
Legal
Sage Sues Partner Biogen After Unsolicited Takeover Offer
January 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Notch Therapeutics to ‘Significantly Reduce’ Workforce
January 17, 2025
 · 
104 min read
 · 
BioSpace Editorial Staff
Human hands holding colorful puzzle pieces in 80s retro collage vector illustration. Mixed media artwork for concept of cooperation, teamwork, partnership and successful solutions.
Editorial
The People Behind Biopharma’s Big Wins: Personal Stories From JPM25
January 17, 2025
 · 
4 min read
 · 
Annalee Armstrong
Chinese cargo containers on map of USA. Import of chenese goods concept. 3D rendered illustration.
China
The Rise of China Innovation in the Time of Trump
January 16, 2025
 · 
4 min read
 · 
Annalee Armstrong